Allergan Reports Advanced Medical Optics' Registration Statement on Form 10 Effective by the SEC.Business Editors IRVINE, Calif.--(BUSINESS WIRE)--May 16, 2002 Allergan, Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) announced today that the Securities and Exchange Commission has declared the Registration Statement on Form 10 for Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc. (AMO) to be effective as of May 14, 2002. In addition, the Internal Revenue Service has ruled that the transaction will qualify as a tax-free distribution. Allergan previously announced it would spin-off the ophthalmic surgical and contact lens care businesses as a new entity to its stockholders by means of a tax-free dividend to Allergan's stockholders of record as of June 14, 2002. The new entity, Advanced Medical Optics, Inc. (AMO), will be established as an independent, publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. . The spin-off is expected to occur on June 29, 2002. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion